Losartan potassium price index

Losartan potassium price December 2025 and outlook (see chart below)

• India:US$49.48/KG, -3.2% down

Business Analytiq assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, or timeliness.

Losartan potassium price index

This post is a summary of the Losartan potassium price developments. The price developments of Losartan potassium are expressed in US$ prices converted FX rates applicable at the time when the price was valid. Losartan potassium price index developments are calculated from multiple separate sources of data to ensure statistical accuracy.

The outlook for Losartan potassium prices is generated from different inputs including:

• Very recent price developments of immediate cost drivers of Losartan potassium prices
• Recent price developments of underlying feedstocks which drive the price of Losartan potassium
• Market futures for both cost drives and feedstocks of Losartan potassium prices
• Adjustment of current supply/demand imbalances in the Losartan potassium market
• Longer term trends in likely demand conditions

What is Losartan Potassium and What Is It Used For

Losartan Potassium is the potassium salt form of the angiotensin II receptor antagonist drug known simply as losartan. It works by blocking the binding of the hormone angiotensin II to the AT₁ receptor, which causes blood vessels to relax and lowers blood pressure. It is primarily used to treat high blood pressure (hypertension) in adults and children (from about 6 years up) and to protect kidney function in patients with type 2 diabetes and hypertension who have impaired renal function or proteinuria. It is also used (in some cases) for chronic heart failure when ACE inhibitors are not appropriate.

How is Losartan Potassium Used

Losartan Potassium is administered orally (tablets). Typical doses depend on the indication, patient age, kidney and liver function, and concomitant medications. Its mechanism: it selectively and competitively binds to the AT₁ receptor, thus blocking angiotensin II–mediated vasoconstriction and aldosterone‑mediated sodium retention, ultimately causing vasodilation and lowering of blood pressure. Because of these effects, care must be taken in certain populations (e.g., during pregnancy, renal impairment).

How Large Is the Global Market for Losartan Potassium

The global market for losartan potassium (both as finished tablets and as active pharmaceutical ingredient, API) shows significant and growing demand. According to one source, the market size for losartan potassium tablets was estimated at approximately **USD 2.66 billion in 2024**, with a projected growth to about **USD 5.21 billion by 2035**, at a CAGR of ~6.3%. Another source estimates the API market at USD 1,652.2 million (~USD 1.65 billion) in 2024, with growth of ~5.5% to 2031. Additional data shows market volume size of ~23.8 thousand tonnes in 2023, expected to reach ~35.4 thousand tonnes by 2032 (CAGR ~4.5%) for losartan potassium globally.

Where Is Losartan Potassium Produced

Production of losartan potassium (especially its API) is concentrated in several countries with strong generics and bulk‑API manufacturing capacity. India is one of the largest producers and exporters — for example, global trade data shows India accounting for around 86–88% of export shipments in a recent period. China is also a key producer of the API; e.g., one report identifies a manufacturing site for losartan potassium API at Zhejiang Huahai Pharmaceutical Co., Ltd in Linhai, Zhejiang, China. } Many manufacturers in India (e.g., Dr. Reddy’s Laboratories in Hyderabad) list losartan potassium API among their portfolio.